Table 2 Glaucoma medications
From: Link between neurodegeneration and trabecular meshwork injury in glaucomatous patients
Glaucoma medications, | Cataract | POAG |
|---|---|---|
No. mean ± SD | 0 | 2.5 ± 0.78 |
Range | 0 | 1–4 |
β-blockers | 0 | 22(92) |
Prostaglandin analoguess | 0 | 16(67) |
Carbonic anhydrase inhibitors | 0 | 12(50) |
α2-agonist | 0 | 10(42) |